SPC151
Carfílsómíb mögulega á formi lyfjarfæðilega hæfs salts
Status:
VeittApplication date:
6.4.2016Application published:
15.5.2016Grant published:
15.5.2017
Max expiry date:
7.8.2030Next due date:
31.8.2026Medicine name:
KyprolisMedicine for children:
No
Timeline
Today
6.4.2016Application
15.5.2016Publication
15.5.2017Registration
7.8.2026Expires
Marketing license
IS authorization number:
EU/1/15/1060/001Date:
24.11.2015
Foreign authorization number:
EU/1/15/1060Date:
19.11.2015
Owner
Name:
Onyx Therapeutics, Inc.Address:
249 E. Grand Avenue, South San Francisco, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP1781688
Annual fees
Number
Paid
Expires
Payer
Number: 1
Paid: 8.8.2025
Expires: 7.8.2026
Payer: Árnason Faktor ehf.